GLOBAL MACRO | CONSUMER | ETF PERFORMANCE |
|
We are excited to host a Cannabis Legalization conversation with Zander Abrams, the Founder of the Cannabis Policy Forum. The topics we want to cover can undoubtedly take more than 60 minutes, but we will try to cover as many topics as we can from the thoughts below: A look back on 2021
2022 Cannabis policy preview
Focus on Social Equity
Election Preview
Please email any thoughts or questions to ConsumablesPro.com Cannabis/Consumables Pro Subscribers CLICK HERE for event details (includes video and materials link) |
Ascend Wellness
Ascend Wellness Holdings, Inc. announced it had received final approval from the New York Cannabis Control Board and the Office of Cannabis Management of the CCB for its previously announced definitive investment agreement with MedMen NY Inc., AWH has given notice to MedMen of its intent to close the transactions contemplated by the Investment Agreement imminently.
Curaleaf Holdings
Curaleaf Holdings on Dec. 28 announced the acquisition of Bloom Dispensaries, a private, integrated Arizona marijuana operator, in a deal valued at $211 million. Bloom has four retail dispensaries in Phoenix, Tucson, Peoria, and Sedona and two adjacent cultivation and processing facilities totaling approximately 63,500 square feet. The total consideration of $211 million will be paid using $51 million in cash and $160 million in notes, which are recourse only to the assets and equity of Bloom without any guarantee from Massachusetts-based Curaleaf. The notes are structured in three series, with $50 million, $50 million, and $60 million due on the transaction's first, second, and third anniversaries, respectively. The purchase price represents 3.2X Bloom's estimated 2021 revenue and roughly 8.0X estimate EBITDA. (Bloom has 40%+ EBITDA margins, according to the PR.
Howard Penney
